Computed Tomographic and Ultrasonographic Features of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia in Cats
Veterinary Radiology & Ultrasound · 2025
DOI: 10.1111/vru.70086 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Veterinary Radiology & Ultrasound, 2025. Verfasst von Hongji Yoon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Medical Imaging, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Cat Diseases, Gastrointestinal Diseases, Tomography, X-Ray Computed. Die Arbeit nennt 27 Literaturangaben.
Abstract (Originalsprache)
This study aimed to characterize the computed tomographic (CT) and ultrasonographic features of feline gastrointestinal eosinophilic sclerosing fibroplasia (FGESF) and its concurrent abnormalities. A retrospective multicenter study was conducted on 16 cats with histopathologically confirmed FGESF. CT and ultrasonographic characteristics were retrospectively evaluated to assess the lesion location, shape, size, and layering patterns. The contrast enhancement patterns, including the attenuation values, were analyzed qualitatively and quantitatively. Concurrent abnormalities, such as lymphadenopathy, gastrointestinal (GI) obstruction, and perforation, were also assessed. FGESF predominantly affected young to middle‐aged cats (median age: 3.5 years; range: 9 months–9 years), and Ragdolls were the most overrepresented breed among purebred cats. GI involvement was observed in 14 of 16 cases, most commonly in the proximal duodenum (33%). Lesion growth patterns were significantly associated with anatomical location; all proximal duodenal and pyloric lesions demonstrated endophytic growth ( p = 0.018). Common CT findings included heterogeneous contrast enhancement (86%), mucosal layer enhancement (86%), and ulceration (50%). Ultrasonography revealed intraparenchymal hyperechoic areas (100%), heterogeneous echotexture (93%), and mixed echogenicity (93%). Concurrent abdominal lymphadenopathy was present in 93% of cases, with 85% showing marked enlargement (>10 mm). GI obstruction (21%) and perforation (14%) were less common; however, perforation cases exhibited poor prognosis, and none of the affected cats survived beyond 24 h postoperatively. These findings support the inclusion of FGESF in the differential diagnosis of GI mass‐forming conditions in cats and highlight the utility of CT and ultrasonography for the comprehensive assessment of primary lesions and concurrent abnormalities.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Veterinary Medical Imaging, College of Veterinary Medicine, Konkuk University, Seoul, Republic of Korea.
- Research Institute, Green Vet, Yongin, Republic of Korea.
- Nowon VIP Animal Medical Center, Seoul, Republic of Korea.
- SD Animal Medical Center, Seoul, Republic of Korea.
- Ilsan Animal Medical Center, Goyang, Republic of Korea.
- V Animal Medical Center, Jeju, Republic of Korea.
ORCID-Profile: Hongji Yoon, Hayoung Lim, Jaehwan Kim, Kidong Eom
Zitieren
APA
Yoon, H., Kim, M., Lim, H., Lee, S., Lee, M., Jung, J., Lee, J., Im, C., Lee, S., Kim, J., & Eom, K. (2025). Computed Tomographic and Ultrasonographic Features of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia in Cats. Veterinary Radiology & Ultrasound. https://doi.org/10.1111/vru.70086
Vancouver
Yoon H, Kim M, Lim H, Lee S, Lee M, Jung J, et al. Computed Tomographic and Ultrasonographic Features of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia in Cats. Veterinary Radiology & Ultrasound. 2025. doi:10.1111/vru.70086
BibTeX
@article{Yoon2025,
author = {Yoon, Hongji and Kim, Myounghun and Lim, Hayoung and Lee, Seungjun and Lee, Minsu and Jung, Joohyun and Lee, Jungha and Im, Changgyu and Lee, Sanghee and Kim, Jaehwan and Eom, Kidong},
title = {Computed Tomographic and Ultrasonographic Features of Feline Gastrointestinal Eosinophilic Sclerosing Fibroplasia in Cats},
journal = {Veterinary Radiology & Ultrasound},
year = {2025},
doi = {10.1111/vru.70086}
}
EUVIMED